The labor union of Samsung Biologics has postponed its second general strike, which was scheduled to take place on Oct. 26.
On Tuesday, the Samsung Biologics union stated in a position paper that "a strategic shift is necessary in light of the court's decision," and announced that it would "temporarily postpone the (strike schedule planned for next week)."
Previously, the First Civil Division of the Incheon Branch of the Seoul High Court ruled on the 16th to grant all nine production lines requested by the company side in the appeal hearing regarding the injunction against labor disputes filed by Samsung Biologics.
In accordance with the court's ruling, the union must maintain the same level of personnel, operating hours, and scale of operations as usual across the entire production process even during a strike. As the scope of the strike ban has effectively expanded to the entire production line, unlike during the first general strike in May, the union's strategy of pressuring the company side by causing "widespread losses through production stoppage" is inevitably facing difficulties.
However, the union did not express its intention to withdraw the strike. The union stated on that day, "As we are preparing for an extraordinary general meeting and other events on the 22nd to secure dispute funds, we are not publicly announcing a specific strike schedule." It added, "The union requested negotiations from the company side on the evening of the 19th," and noted that "the company has expressed its intention to consider how to engage in dialogue."
Samsung Biologics stated, "We have received an official document from the union notifying us of the strike postponement and requesting negotiations," and added, "The company will continue to make efforts to maintain dialogue with the union going forward."
in THEBIO
